We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$49B
AUM Growth
+$3.11B
Cap. Flow
+$228M
Cap. Flow %
0.47%
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$282M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$205M
3
COP icon
ConocoPhillips
COP
+$203M
4
FTV icon
Fortive
FTV
+$200M
5
MRK icon
Merck
MRK
+$178M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$665M
2
XOM icon
ExxonMobil
XOM
+$332M
3
BURL icon
Burlington
BURL
+$242M
4
EYE icon
National Vision
EYE
+$186M
5
CXO
CONCHO RESOURCES INC.
CXO
+$175M

Sector Composition

Rank Sector Weight
1 Technology 20.67%
2 Healthcare 17.99%
3 Financials 14.03%
4 Consumer Discretionary 11.97%
5 Communication Services 8.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PDYNW icon
926
Palladyne AI Corp Warrants
PDYNW
$213K
$358K ﹤0.01%
+550,000
New +$394K
DCGOW
927
DELISTED
DocGo Inc. Warrants
DCGOW
$350K ﹤0.01%
+333,333
New +$516K
CRU.WS
928
DELISTED
Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRU.WS
$348K ﹤0.01%
+250,000
New +$391K
FOXO.WS
929
DELISTED
FOXO Technologies Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FOXO.WS
$318K ﹤0.01%
+600,000
New +$542K
PACXW
930
DELISTED
Pioneer Merger Corp. Warrant
PACXW
$311K ﹤0.01%
+333,333
New +$384K
AKICW
931
DELISTED
Sports Ventures Acquisition Corp. Warrant
AKICW
$302K ﹤0.01%
+333,333
New +$367K
POWRW
932
DELISTED
Powered Brands Warrants
POWRW
$300K ﹤0.01%
+400,000
New +$428K
FCACW
933
DELISTED
Falcon Capital Acquisition Corp. Warrant
FCACW
$282K ﹤0.01%
+183,332
New +$406K
HYZNW
934
DELISTED
Hyzon Motors Inc. Warrants
HYZNW
$281K ﹤0.01%
150,000
-150,000
-50% -$423K
FSSIW
935
DELISTED
Fortistar Sustainable Solutions Corp. Warrant
FSSIW
$263K ﹤0.01%
+375,000
New +$251K
PV.WS
936
DELISTED
Primavera Capital Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PV.WS
$246K ﹤0.01%
+300,000
New +$317K
CLIM.WS
937
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
CLIM.WS
$242K ﹤0.01%
+220,000
New +$346K
CLAS.WS
938
DELISTED
Class Acceleration Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
CLAS.WS
$233K ﹤0.01%
+375,000
New +$323K
FVT.WS
939
DELISTED
Fortress Value Acquisition Corp. III Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVT.WS
$208K ﹤0.01%
+200,000
New +$273K
HCIIW
940
DELISTED
Hudson Executive Investment Corp. II Warrant
HCIIW
$195K ﹤0.01%
+250,000
New +$238K
SSAAW
941
DELISTED
Science Strategic Acquisition Corp. Alpha Warrant
SSAAW
$180K ﹤0.01%
+300,000
New +$187K
ZWRKW
942
DELISTED
Z-Work Acquisition Corp. Warrant
ZWRKW
$180K ﹤0.01%
+250,000
New +$173K
BZFDW icon
943
BuzzFeed Inc Warrant
BZFDW
$670K
$178K ﹤0.01%
+200,000
New +$177K
IIIIW
944
DELISTED
INSU Acquisition Corp. III Warrant
IIIIW
$169K ﹤0.01%
+177,476
New +$295K
TMAC.WS
945
DELISTED
The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TMAC.WS
$153K ﹤0.01%
+250,000
New +$163K
VIA
946
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$144K ﹤0.01%
2,695
– –
FCAX.WS
947
DELISTED
Fortress Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FCAX.WS
$99K ﹤0.01%
+100,000
New +$122K
CAS.WS
948
DELISTED
Cascade Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class
CAS.WS
$78K ﹤0.01%
+86,525
New +$114K
ABNB icon
949
Airbnb
ABNB
$90.5B
– –
-115,000
Closed -$16.9M
ACAD icon
950
Acadia Pharmaceuticals
ACAD
$4.96B
– –
-80,000
Closed -$4.28M
36 37
38
39 40

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
  • Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
  • Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
  • Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
  • Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
  • Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
  • Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.

Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.